This article has been updated with comments from Illumina.
By a GenomeWeb staff reporter
In its suit, filed last August, LadaTech claimed that Illumina's Genome Analyzer and related products and services infringe a DNA amplification patent it holds.
LadaTech initially filed the suit in August, and said that Illumina refused to enter into a license agreement for the patent.
The suit claims that Illumina's Genome Analyzer and related products and services infringe a patent originally issued to Genelabs and now held by a firm called LadaTech.
Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.
The New York Times reports that a number of companies and research institutes are pursuing gene therapies.
Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.
In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.